Tikvah Management LLC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 87 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Tikvah Management LLC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$4,151,908
-18.3%
1,313,8950.0%1.49%
-13.9%
Q2 2023$5,084,774
+23.3%
1,313,895
-11.8%
1.73%
+2.0%
Q1 2023$4,124,239
+53.9%
1,488,8950.0%1.70%
+32.4%
Q4 2022$2,680,011
-15.1%
1,488,8950.0%1.28%
-12.3%
Q3 2022$3,156,000
-21.2%
1,488,8950.0%1.46%
-15.5%
Q2 2022$4,005,000
-38.0%
1,488,8950.0%1.73%
-16.5%
Q1 2022$6,462,000
+1.3%
1,488,895
+20.9%
2.07%
+16.1%
Q4 2021$6,381,000
-99.9%
1,231,835
+73.9%
1.78%
+51.4%
Q3 2021$4,350,436,000708,5401.18%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders